Consuming fat before carbohydrates reduces post-meal blood glucose
View as a Web Page
News Medical
 
  Hepatology Hepatology logo  
  The latest hepatology news from News Medical  
 As GLP-1 drugs become more complex, their effects on the heart are getting harder to predictAs GLP-1 drugs become more complex, their effects on the heart are getting harder to predict
 
A brief report reviews emerging GLP-1 receptor co-agonists that also target GIPR, GCGR, and other receptors, examining their metabolic benefits alongside known and predicted cardiac effects. The authors highlight substantial species differences, warning that mouse heart studies may fail to predict responses in human cardiac tissue and that many proposed cardiac effects still require direct testing.
 
 
 Consuming fat before carbohydrates reduces post-meal blood glucoseConsuming fat before carbohydrates reduces post-meal blood glucose
 
In treating diabetes, post-meal elevation of glucose levels is an important therapeutic target. Existing clinical studies indicate that eating vegetables, protein, or fat before carbohydrates can moderate a post-meal rise in blood glucose, pointing to the potential of meal-sequencing as a simple and sustainable dietary strategy.
 
   Pancreatic cancer cells continuously reshape DNA to evade treatmentPancreatic cancer cells continuously reshape DNA to evade treatment
 
A new analysis of nearly half a million cells from dozens of pancreatic tumors, led by researchers at UC San Diego Moores Cancer Center and New York University (NYU), reveals how pancreatic cancer cells continuously reshape their genetic makeup over time, enabling them to evade treatment.
 
   Why one gut microbe is attracting attention in heart failure researchWhy one gut microbe is attracting attention in heart failure research
 
Researchers found that chronic systolic heart failure caused by nonischemic cardiomyopathy was associated with reduced gut microbial diversity, depletion of Bifidobacterium, and lower microbial short-chain fatty acid production potential. Higher Bifidobacterium abundance and higher circulating indole-3-propionic acid levels were associated with milder disease and clinical improvement, although the findings do not establish causality.
 
   Molecular regulator CA8 may offer new therapeutic target for type 2 diabetesMolecular regulator CA8 may offer new therapeutic target for type 2 diabetes
 
Maintaining healthy blood glucose levels involves striking a balance between the glucose produced by the liver during fasting, and the insulin released from pancreatic beta cells after meals.
 
 Study finds oral hormone replacement therapy increases venous thromboembolism risk
 
Study finds oral hormone replacement therapy increases venous thromboembolism riskCurrent use of oral menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is associated with an increased risk of blood clots in legs / lungs regardless of dose or treatment duration, finds a large Danish study published by The BMJ today.
 
 
 New study identifies protein factor linked to chronic liver disease
 
New study identifies protein factor linked to chronic liver diseaseThe mechanisms that cause the world's most common chronic liver disease — Metabolic dysfunction-associated steatotic liver disease (MASLD) — to develop and progress are not still fully understood.
 
 
 Late-night snacking may affect liver health
 
Late-night snacking may affect liver healthNew research led by Oregon Health & Science University suggests you should think twice about indulging in a late-night snack if you'd like to preserve liver health.
 
 
 New research unveils role of innate immune system in pancreatic cancer
 
New research unveils role of innate immune system in pancreatic cancerResearchers from Adelaide University have demonstrated that blocking a specific immune system gene can reduce pancreatic cancer tumor formation.
 
 
 Petrelintide produces double-digit weight loss with fewer side effects
 
Petrelintide produces double-digit weight loss with fewer side effectsNew research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Diabetes & Endocrinology shows that weekly injections with the new amylin-based obesity drug petrelintide can enable those treated to lose more than 10% of their body weight – generally lower than existing incretin-based (GLP-1 RA) drugs, but also with far fewer side effects.
 
 
 Siemens Healthineers and Novo join forces to advance care for people living with MASLD and MASH
 
Siemens Healthineers and Novo join forces to advance care for people living with MASLD and MASHSiemens Healthineers and Novo have announced a collaboration focused on advancing care for people living with metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH).
 
 
 Baseline liver fibrosis severity predicts treatment response in patients with HBeAg-positive CHB
 
Baseline liver fibrosis severity predicts treatment response in patients with HBeAg-positive CHBThe impact of baseline liver fibrosis severity on the effectiveness of pegylated interferon (Peg-IFN) combined with nucleos(t)ide analogs (NAs) in the treatment of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) has not been fully clarified.
 
 
 From turmeric to fenugreek, scientists examine nature’s potential role in diabetes care
 
From turmeric to fenugreek, scientists examine nature’s potential role in diabetes careA narrative review examined how curcumin, honey, culinary spices, and traditional remedies may influence oxidative stress, inflammation, mitochondrial function, and insulin signaling in diabetes. Although experimental research and some clinical trials suggest potential metabolic benefits, the authors emphasize that larger, well-controlled studies are needed to establish their effectiveness and safety alongside conventional treatments.
 
 
 Study identifies three cell clusters driving pancreatic cancer-induced cachexia
 
Study identifies three cell clusters driving pancreatic cancer-induced cachexiaResearch published today in Cell identifies three small subclusters of cells driving pancreatic cancer-induced cachexia, a muscle-wasting and fat-loss condition that makes patients less tolerant of cancer treatment.
 
 
 Intestinal enzyme links microbial metabolism to MASH progression
 
Intestinal enzyme links microbial metabolism to MASH progressionMetabolic dysfunction-associated steatohepatitis (MASH) is often viewed through the lens of hepatic lipid accumulation, inflammation and fibrosis. A new study published in eGastroenterology shifts attention upstream, identifying intestinal neutral ceramidase as a gut-derived driver of MASH progression through its effects on microbial metabolism, epithelial signalling and intestinal barrier function.
 
 
 High-dose taurine aggravates alcohol-induced liver injury, study shows
 
High-dose taurine aggravates alcohol-induced liver injury, study showsThe researchers first tested whether taurine could compensate for reduced intestinal taurine availability and protect against alcohol-induced liver damage.
 
 
 Long-term "Food Is Medicine" program improves cardiometabolic health in adults
 
Long-term "Food Is Medicine" program improves cardiometabolic health in adultsProviding people with nutritious foods can improve the management of chronic metabolic diseases such as type 2 diabetes and hypertension.
 
 
 Routine liver cancer screening extends lives for patients with alcohol-associated cirrhosis
 
Routine liver cancer screening extends lives for patients with alcohol-associated cirrhosisA new study led by investigators from Mass General Brigham found routine liver cancer screening to be cost-effective and life-extending for individuals with alcohol-associated cirrhosis, even when their annual risk of developing liver cancer is less than half the risk level guiding current screening recommendations.
 
 
 Five-session SBRT preserves quality of life before pancreatic cancer surgery
 
Five-session SBRT preserves quality of life before pancreatic cancer surgeryPatients preparing for pancreatic cancer surgery maintained better physical function and experienced less fatigue with five treatments of stereotactic body radiation therapy (SBRT) than with 28 treatments of conventional radiation therapy given with chemotherapy, according to a randomized phase 2 clinical trial.
 
 
 Daily probiotics help prevent severe gut disease in preterm babies
 
Daily probiotics help prevent severe gut disease in preterm babiesProbiotic supplementation in very preterm infants is linked to lower rates of necrotizing enterocolitis and mortality, according to a nationwide Swedish study.
 
 
 Single-cell analysis reveals how pancreatic cancer evades treatment
 
Single-cell analysis reveals how pancreatic cancer evades treatmentAn analysis of nearly half a million cells from dozens of patients' tumors reveals how cancer cells continuously reshape their genetic makeup over time, enabling them to evade treatment for one of the deadliest forms of cancer.
 
 
 SPRED2 coordinates three signaling pathways to suppress liver cancer stemness
 
SPRED2 coordinates three signaling pathways to suppress liver cancer stemnessLiver cancer is the fifth most commonly diagnosed cancer and the second leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) accounts for 70-85% of primary liver cancers, and its five-year recurrence rate can reach 70-80%.
 
 
 RNA modification enzyme FTO shows therapeutic promise in gastrointestinal cancers
 
RNA modification enzyme FTO shows therapeutic promise in gastrointestinal cancersA new review in Genes & Diseases highlights FTO, an enzyme involved in RNA modification, as a potentially important biomarker and therapeutic target across gastrointestinal cancers.
 
 
 Study compares shifting pancreatic cancer burdens in the United States and China
 
Study compares shifting pancreatic cancer burdens in the United States and ChinaPancreatic cancer remains one of the deadliest malignancies worldwide, carrying a five-year survival rate of roughly 10% and a heavy toll in disability-adjusted life years.
 
 
 How does 3D bioprinting improve drug screening accuracy?
 
How does 3D bioprinting improve drug screening accuracy?3D bioprinting improves drug screening accuracy with physiologically relevant tissue models.
 
 
 UCLA scientist develops new way to map cellular metabolism
 
UCLA scientist develops new way to map cellular metabolismNutrition advice is everywhere. Eat more protein. Cut back on sugar. Get more fiber. But beneath all that advice is a surprisingly basic gap in our understanding: Scientists still have a limited view of what happens when specific nutrients reach individual cells inside the body.
 
 
 AI tool provides early warning for organ failure in acute pancreatitis
 
AI tool provides early warning for organ failure in acute pancreatitisAcute pancreatitis (AP) is one of the most common acute digestive disorders worldwide, and its most feared complication-persistent organ failure-drives mortality rates of 30% to 50%.
 
 
 Could mRNA vaccine technology help repair damaged livers?
 
Could mRNA vaccine technology help repair damaged livers?Research indicates that brief cellular reprogramming and mRNA nanoparticles can enhance liver repair, offering new strategies for acute liver injury recovery.
 
 
 Could a hormone from our bones reveal early signs of insulin resistance?
 
Could a hormone from our bones reveal early signs of insulin resistance?Research reveals a link between osteocalcin and insulin resistance in obese children, suggesting early metabolic changes before glucose tolerance impairment.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney

Copyright © 2000-2026